v3.26.1
SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE - EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Earnings attributable to common shares, basic $ 796 $ 461 $ 1,833 $ 1,367
Earnings attributable to common shares, diluted $ 796 $ 461 $ 1,833 $ 1,367
Weighted-average common shares outstanding for basic EPS (in shares) 654,038,000 652,664,000 653,815,000 652,330,000
Dilutive effect of common shares sold forward (in shares) 518,000 101,000 500,000 51,000
Dilutive effect of stock options and RSUs (in shares) 1,389,000 459,000 1,403,000 742,000
Weighted-average common shares outstanding for diluted EPS (in shares) 655,945,000 653,224,000 655,718,000 653,123,000
Earnings per share, basic (in dollars per share) $ 1.22 $ 0.71 $ 2.80 $ 2.10
Earnings per share, diluted (in dollars per share) $ 1.21 $ 0.71 $ 2.80 $ 2.09
Vested RSUs included in basic WASO (in shares) 365,000 499,000 375,000 507,000
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Non-qualified stock options granted (in shares)     568,052  
Performance-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     441,749  
Service-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     191,383  
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Antidilutive securities excluded from earnings per share (in shares) 595,546 1,376,618 578,643 949,450